Markets

Fundamentals in Focus for AMETEK, Inc. (AME)

AMETEK, Inc. (NYSE:AME) is an interesting stock at present. Now trading with a market value of 14.20B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. As the day-to-day narrative ebbs and flows for this company, it is more important than ever to step back and get a bird’s eye view of the fundamental reality under the surface of this story.

AMETEK, Inc. (NYSE:AME) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For AME, the company currently has 570.23 million of cash on the books, which is offset by 337.95 million in current liabilities. The trend over time is important to note. In this case, the company’s debt has been growing. The company also has 7.3 billion in total assets, balanced by 3.89 billion in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

AMETEK, Inc. (AME) saw 129.06 million in free cash flow last quarter, representing a quarterly net change in cash of -147.03 million. Perhaps most importantly where cash movements are concerned, the company saw about 142.44 million in net operating cash flow.

AMETEK, Inc. (NYSE:AME) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 1.01 billion in total revenues. That represents a quarterly year/year change in revenues of 0.07 in sequential terms, the (AME) saw sales decline by 0.04.



But what about the bottom line? After all, that’s what really matters in the end. AMETEK, Inc. (AME) is intriguing when broken down to its core data. The cost of selling goods last quarter was 664.94 million, yielding a gross basic income of 342.75 million. For shareholders, given the total diluted outstanding shares of 231 million, this means overall earnings per share of 0.60. Note, this compares with a consensus analyst forecast of 0.62 in earnings per share for its next fiscal quarterly report.

Is AMETEK, Inc. (NYSE:AME) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 2.74 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 22.79. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on AMETEK, Inc..

Previous ArticleNext Article

Related Post

Microbot Medical Inc. (MBOT) Just Flashed an Extre... Microbot Medical Inc. (NASDAQ:MBOT) gained 17.48% in Friday’s trading session, going up from its prior closing price of $1.03 to $1.21. The price has ...
AVEO Pharmaceuticals, Inc. (AVEO) vs. Novavax, Inc... AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) and Novavax, Inc. (NASDAQ:NVAX) are the two most active stocks in the Biotechnology industry based on today’s...
Curis, Inc. (CRIS): How Do the Books Stack Up? Curis, Inc. (NASDAQ:CRIS) is one of the more popular stocks investors are adding into their watchlist. Now trading with a market value of 265.58M, the...
Are Investors Buying or Selling Abeona Therapeutic... Recent insider trends for Abeona Therapeutics Inc. (NASDAQ:ABEO) have caught the attention of investors. Analysts study insider data to get a sense of...
Adverum Biotechnologies, Inc. (ADVM): How Do the B... Adverum Biotechnologies, Inc. (NASDAQ:ADVM) trade is getting exciting but lets take a deeper look whether it is as good a moment. Now trading with a m...

Leave a Reply

Your email address will not be published. Required fields are marked *